MONDELEZ INTERNATIONAL INC-A (MDLZ)
US6092071058 - Common Stock
MDLZ gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 92 industry peers in the Food Products industry. MDLZ scores excellent on profitability, but there are some minor concerns on its financial health. MDLZ has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
MDLZ had positive earnings in the past year.
In the past year MDLZ had a positive cash flow from operations.
Each year in the past 5 years MDLZ has been profitable.
In the past 5 years MDLZ always reported a positive cash flow from operatings.
1.2 Ratios
MDLZ's Return On Assets of 5.40% is fine compared to the rest of the industry. MDLZ outperforms 65.93% of its industry peers.
MDLZ has a Return On Equity of 14.25%. This is in the better half of the industry: MDLZ outperforms 75.82% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.04%, MDLZ belongs to the top of the industry, outperforming 80.22% of the companies in the same industry.
MDLZ had an Average Return On Invested Capital over the past 3 years of 6.55%. This is below the industry average of 8.95%.
The last Return On Invested Capital (9.04%) for MDLZ is above the 3 year average (6.55%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.4% | ||
| ROE | 14.25% | ||
| ROIC | 9.04% |
ROA(3y)5.72%
ROA(5y)5.7%
ROE(3y)14.27%
ROE(5y)14.03%
ROIC(3y)6.55%
ROIC(5y)6.31%
1.3 Margins
MDLZ has a Profit Margin of 10.97%. This is amongst the best in the industry. MDLZ outperforms 84.62% of its industry peers.
In the last couple of years the Profit Margin of MDLZ has remained more or less at the same level.
Looking at the Operating Margin, with a value of 17.60%, MDLZ belongs to the top of the industry, outperforming 91.21% of the companies in the same industry.
MDLZ's Operating Margin has been stable in the last couple of years.
With an excellent Gross Margin value of 40.34%, MDLZ belongs to the best of the industry, outperforming 95.60% of the companies in the same industry.
MDLZ's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.6% | ||
| PM (TTM) | 10.97% | ||
| GM | 40.34% |
OM growth 3Y0.4%
OM growth 5Y0.42%
PM growth 3Y0.97%
PM growth 5Y1.49%
GM growth 3Y-0.93%
GM growth 5Y-0.86%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MDLZ is creating some value.
The number of shares outstanding for MDLZ has been reduced compared to 1 year ago.
MDLZ has less shares outstanding than it did 5 years ago.
MDLZ has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.56 indicates that MDLZ is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of MDLZ (2.56) is comparable to the rest of the industry.
The Debt to FCF ratio of MDLZ is 5.48, which is a neutral value as it means it would take MDLZ, 5.48 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 5.48, MDLZ is doing good in the industry, outperforming 67.03% of the companies in the same industry.
A Debt/Equity ratio of 0.61 indicates that MDLZ is somewhat dependend on debt financing.
MDLZ has a Debt to Equity ratio (0.61) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 5.48 | ||
| Altman-Z | 2.56 |
ROIC/WACC1.19
WACC7.62%
2.3 Liquidity
A Current Ratio of 0.68 indicates that MDLZ may have some problems paying its short term obligations.
With a Current ratio value of 0.68, MDLZ is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
A Quick Ratio of 0.50 indicates that MDLZ may have some problems paying its short term obligations.
MDLZ has a Quick ratio of 0.50. This is in the lower half of the industry: MDLZ underperforms 75.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.68 | ||
| Quick Ratio | 0.5 |
3. Growth
3.1 Past
MDLZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.75%, which is quite good.
The Earnings Per Share has been growing slightly by 6.38% on average over the past years.
MDLZ shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.35%.
The Revenue has been growing slightly by 6.79% on average over the past years.
EPS 1Y (TTM)13.75%
EPS 3Y8.1%
EPS 5Y6.38%
EPS Q2Q%20.73%
Revenue 1Y (TTM)14.35%
Revenue growth 3Y10.66%
Revenue growth 5Y6.79%
Sales Q2Q%1.94%
3.2 Future
Based on estimates for the next years, MDLZ will show a small growth in Earnings Per Share. The EPS will grow by 6.39% on average per year.
The Revenue is expected to grow by 4.04% on average over the next years.
EPS Next Y7.72%
EPS Next 2Y3.4%
EPS Next 3Y6%
EPS Next 5Y6.39%
Revenue Next Year1.64%
Revenue Next 2Y3.03%
Revenue Next 3Y3.39%
Revenue Next 5Y4.04%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 18.81 indicates a rather expensive valuation of MDLZ.
Based on the Price/Earnings ratio, MDLZ is valued a bit cheaper than 65.93% of the companies in the same industry.
MDLZ is valuated rather cheaply when we compare the Price/Earnings ratio to 30.16, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 19.35, MDLZ is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MDLZ indicates a somewhat cheap valuation: MDLZ is cheaper than 64.84% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.06. MDLZ is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.81 | ||
| Fwd PE | 19.35 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as MDLZ.
MDLZ's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. MDLZ is cheaper than 60.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.38 | ||
| EV/EBITDA | 14.59 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of MDLZ may justify a higher PE ratio.
PEG (NY)2.44
PEG (5Y)2.95
EPS Next 2Y3.4%
EPS Next 3Y6%
5. Dividend
5.1 Amount
MDLZ has a Yearly Dividend Yield of 2.69%.
MDLZ's Dividend Yield is a higher than the industry average which is at 3.59.
Compared to an average S&P500 Dividend Yield of 2.22, MDLZ pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.69% |
5.2 History
On average, the dividend of MDLZ grows each year by 11.47%, which is quite nice.
MDLZ has paid a dividend for at least 10 years, which is a reliable track record.
MDLZ has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)11.47%
Div Incr Years10
Div Non Decr Years10
5.3 Sustainability
57.16% of the earnings are spent on dividend by MDLZ. This is a bit on the high side, but may be sustainable.
The dividend of MDLZ is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP57.16%
EPS Next 2Y3.4%
EPS Next 3Y6%
MONDELEZ INTERNATIONAL INC-A
NASDAQ:MDLZ (10/31/2024, 8:19:04 PM)
After market: 68.23 -0.25 (-0.37%)68.48
-1.31 (-1.88%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap91.48B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.69% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.81 | ||
| Fwd PE | 19.35 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)2.44
PEG (5Y)2.95
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.4% | ||
| ROE | 14.25% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 17.6% | ||
| PM (TTM) | 10.97% | ||
| GM | 40.34% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.68 | ||
| Quick Ratio | 0.5 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)13.75%
EPS 3Y8.1%
EPS 5Y
EPS Q2Q%
EPS Next Y7.72%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)14.35%
Revenue growth 3Y10.66%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y